The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)-Reference-Cited by-同舟云学术

The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

Published:2012-12 Issue:6 Volume:164 Page:878-883
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Gullestad Lars,Ueland Thor,Kjekshus John,Nymo Ståle H.,Hulthe Johannes,Muntendam Pieter,McMurray John J.V.,Wikstrand John,Aukrust Pål

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference12 articles.

1. Basic mechanisms in congestive heart failure. Recognizing the role of proinnflammatory cytokines;Mann;Chest,1994

2. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction;Sharma;Circulation,2004

3. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis;Henderson;Am J Pathol,2008

4. Utility of amino-terminal pro–brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure;van Kimmenade;J Am Coll Cardiol,2006

5. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study;Lok;Clin Res Cardiol,2010

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Pathobiology of Myocardial Recovery and Remission: From Animal Models to Clinical Observations in Heart Failure Patients;Methodist DeBakey Cardiovascular Journal;2024

2. Multifaceted role of cardiovascular biomarkers;Indian Heart Journal;2023-03

3. Cardiac Biomarkers in the Progression to Heart Failure in Hypertension;Updates in Hypertension and Cardiovascular Protection;2023

4. Impact of moderately reduced renal function on the diagnostic and prognostic value of galectin-3 in patients with exertional dyspnea;Advances in Clinical and Experimental Medicine;2022-04-25

5. Clinical Impact of Circulating Galectin-3 on Ventricular Arrhythmias and Heart Failure Hospitalization Independent of Prior Ventricular Arrhythmic Events in Patients with Implantable Cardioverter-defibrillators;Internal Medicine;2022-04-01